Bupropion metabolites and methods of their synthesis and use

Details for Australian Patent Application No. 2005247034 (hide)

Owner Sepracor, Inc.

Inventors Fang, Qun K; Grover, Paul; Senanayake, Chrisantha H

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005247034

Parent 2000269268

Filing date 22 December 2005

Wipo publication date 19 January 2006

Acceptance publication date 11 February 2010

International Classifications

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 January 2006 Application Open to Public Inspection

  Published as AU-B-2005247034

19 January 2006 Complete Application Filed

25 May 2006 Section 223 Application Allowed

  Sepracor, Inc. The time in which to make a further application for a divisional patent has been extended to 08 Jan 2006. Address for service in Australia - Phillips Ormonde & Fitzpatrick 367 Collins Street Melbourne VIC 3000

11 February 2010 Application Accepted

  Published as AU-B-2005247034

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247035-Method of modernising a drive in a lift installation

2005247033-System and method for replicating orthopaedic implant orientation